Serum interleukin-18 binding protein increases with behavior different from IL-18 in patients with diabetic nephropathy.

[1]  C. Dinarello,et al.  High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein. , 2010, Journal of autoimmunity.

[2]  I. Vauhkonen,et al.  Markers of endothelial dysfunction and low-grade inflammation are associated in the offspring of type 2 diabetic subjects. , 2008, Atherosclerosis.

[3]  T. Uzu,et al.  Predictive impact of elevated serum level of IL-18 for early renal dysfunction in type 2 diabetes: an observational follow-up study , 2007, Diabetologia.

[4]  Herbert Tilg,et al.  Adipocytokines: mediators linking adipose tissue, inflammation and immunity , 2006, Nature Reviews Immunology.

[5]  C. Dinarello.  Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. , 2006, The American journal of clinical nutrition.

[6]  H. Makino,et al.  Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes. , 2005, Diabetes care.

[7]  Masafumi Koga,et al.  Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. , 2003, Metabolism: clinical and experimental.

[8]  C. Wong,et al.  Elevated production of interleukin‐18 is associated with renal disease in patients with systemic lupus erythematosus , 2002, Clinical and experimental immunology.

[9]  G. Fantuzzi,et al.  A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. , 2001, Cytokine.

[10]  H. Okamura,et al.  Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. , 2001, Cytokine & growth factor reviews.

[11]  M Eisenstein,et al.  Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[12]  H. Mühl,et al.  Interferon-gamma mediates gene expression of IL-18 binding protein in nonleukocytic cells. , 2000, Biochemical and biophysical research communications.

[13]  F. Dammacco,et al.  Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18. , 2008, Arthritis and rheumatism.

[14]  G. Fantuzzi,et al.  Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. , 1999, Immunity.